Literature DB >> 20505548

Nitric oxide synthase inhibition attenuates cutaneous vasodilation during postmenopausal hot flash episodes.

Kimberly A Hubing1, Jonathan E Wingo, R Matthew Brothers, Juan Del Coso, David A Low, Craig G Crandall.   

Abstract

OBJECTIVE: The purpose of this study was to test the hypothesis that local inhibition of nitric oxide and prostaglandin synthesis attenuates cutaneous vasodilator responses during postmenopausal hot flash episodes.
METHODS: Four microdialysis membranes were inserted into the forearm skin (dorsal surface) of eight postmenopausal women (mean +/- SD age, 51 +/- 7 y). Ringer solution (control), 10 mM ketorolac (Keto) to inhibit prostaglandin synthesis, 10 mM N-l-arginine methyl ester (l-NAME) to inhibit nitric oxide synthase, and a combination of 10 mM Keto + 10 mM l-NAME were each infused at the separate sites. Skin blood flow at each site was indexed using laser-Doppler flowmetry. Cutaneous vascular conductance (CVC) was calculated as laser-Doppler flux/mean arterial blood pressure and was expressed as a percentage of the maximal calculated CVC (CVCmax) obtained after infusion of 50 mM sodium nitroprusside at all sites at the end of the study. Data from 13 hot flash episodes were analyzed.
RESULTS: At the control site, the mean +/- SD peak increase in CVC was 15.5% +/- 6% CVCmax units. This value was not different relative to the peak increase in CVC at the Keto site (13.0% +/- 5% CVCmax units; P = 0.09). However, the peak increase in CVC during hot flash episodes were attenuated at the l-NAME and l-NAME + Keto sites (7.4% +/- 4% and 8.7% +/- 7% CVCmax units, respectively) relative to both the control and the Keto sites (P < 0.05 for both comparisons). There were no significant differences in the peak increases in sweat rate between any of the sites (P = 0.24).
CONCLUSIONS: These data demonstrate that the mechanism for cutaneous vasodilation during hot flash episodes has a nitric oxide component. Increases in CVC despite the inhibition of prostaglandin synthesis suggest that prostaglandins do not contribute to cutaneous vasodilation during hot flash episodes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505548      PMCID: PMC2945374          DOI: 10.1097/gme.0b013e3181d674d6

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  28 in total

Review 1.  Hot flashes: epidemiology and physiology.

Authors:  F Kronenberg
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Core body temperature and circadian rhythm of hot flashes in menopausal women.

Authors:  R R Freedman; D Norton; S Woodward; G Cornélissen
Journal:  J Clin Endocrinol Metab       Date:  1995-08       Impact factor: 5.958

Review 3.  Hot flashes: phenomenology, quality of life, and search for treatment options.

Authors:  F Kronenberg
Journal:  Exp Gerontol       Date:  1994 May-Aug       Impact factor: 4.032

4.  Cardiovascular responses during the menopausal hot flush.

Authors:  J Ginsburg; J Swinhoe; B O'Reilly
Journal:  Br J Obstet Gynaecol       Date:  1981-09

5.  Laboratory and ambulatory monitoring of menopausal hot flashes.

Authors:  R R Freedman
Journal:  Psychophysiology       Date:  1989-09       Impact factor: 4.016

6.  Estrogen raises the sweating threshold in postmenopausal women with hot flashes.

Authors:  Robert R Freedman; Charla M Blacker
Journal:  Fertil Steril       Date:  2002-03       Impact factor: 7.329

7.  Biophysical and endocrine-metabolic changes during menopausal hot flashes: increase in plasma free fatty acid and norepinephrine levels.

Authors:  M Cignarelli; E Cicinelli; M Corso; M R Cospite; G Garruti; E Tafaro; R Giorgino; S Schonauer
Journal:  Gynecol Obstet Invest       Date:  1989       Impact factor: 2.031

8.  Changes in neurotensin-like immunoreactivity during menopausal hot flashes.

Authors:  F Kronenberg; R E Carraway
Journal:  J Clin Endocrinol Metab       Date:  1985-06       Impact factor: 5.958

9.  Nonneural mediation of digital vasodilation during menopausal hot flushes.

Authors:  R R Freedman; S Woodward; M M Mayes
Journal:  Gynecol Obstet Invest       Date:  1994       Impact factor: 2.031

10.  Is nitric oxide involved in cutaneous vasodilation during body heating in humans?

Authors:  N M Dietz; J M Rivera; D O Warner; M J Joyner
Journal:  J Appl Physiol (1985)       Date:  1994-05
View more
  6 in total

1.  Brain blood flow and cardiovascular responses to hot flashes in postmenopausal women.

Authors:  Rebekah A I Lucas; Matthew S Ganio; James Pearson; Craig G Crandall
Journal:  Menopause       Date:  2013-03       Impact factor: 2.953

2.  Mechanisms of cutaneous vasodilation during the postmenopausal hot flash.

Authors:  David A Low; Kimberley A Hubing; Juan Del Coso; Craig G Crandall
Journal:  Menopause       Date:  2011-04       Impact factor: 2.953

3.  Continuous transdermal nitroglycerin therapy for menopausal hot flashes: a single-arm, dose-escalation trial.

Authors:  Alison J Huang; Steven R Cummings; Michael Schembri; Eric Vittinghoff; Peter Ganz; Deborah Grady
Journal:  Menopause       Date:  2016-03       Impact factor: 2.953

4.  Exercise training reduces the acute physiological severity of post-menopausal hot flushes.

Authors:  Tom G Bailey; N Timothy Cable; Nabil Aziz; Greg Atkinson; Daniel J Cuthbertson; David A Low; Helen Jones
Journal:  J Physiol       Date:  2015-12-30       Impact factor: 5.182

5.  Effects of Electroacupuncture Stimulation at "Zusanli" Acupoint on Hepatic NO Release and Blood Perfusion in Mice.

Authors:  Shu-You Wang; Dong Zhang; Li-Mei Tang; Shun-Yue Li; Mei Wen; Xiao-Jing Song
Journal:  Evid Based Complement Alternat Med       Date:  2015-01-08       Impact factor: 2.629

6.  Novel Evidence-Based Combination of Plant Extracts with Multitarget Mechanisms of Action for the Elimination of Hot Flashes during Menopause.

Authors:  Maria Tsoumani; Panagiota Efstathia Nikolaou; Aikaterini Argyropoulou; Ioulia Tseti; Sofia Mitakou; Ioanna Andreadou
Journal:  Molecules       Date:  2022-02-11       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.